[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366828-105":59,"doc-detail-366828-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","molecular-insights-into-phytochemicals-mediated-epigenetic-regulation-in-preclinical-models-of-breast-cancer","Molecular Insights into Phytochemicals Mediated Epigenetic Regulation in Preclinical Models of Breast Cancer","","Breast cancer is a prevalent malignant disease that is often subdivided into molecular groups, with patient outcomes influenced by these subtypes. The epigenetic features that further stratify patients and shape therapeutic response remain a key explanatory factor. Epigenetic abnormalities are increasingly linked to cancer, and interventions targeting epigenetic pathways have progressed. Phytochemicals act as gene regulators and show preclinical efficacy in breast carcinoma by modulating DNA methylation, histone modifications, non-coding RNAs, and estrogen-associated epigenetic changes, though clinical translation is still limited.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/molecular-insights-into-phytochemicals-mediated-epigenetic-regulation-in-preclinical-models-of-breast-cancer/366828/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/molecular-insights-into-phytochemicals-mediated-epigenetic-regulation-in-preclinical-models-of-breast-cancer/366828.png","ImageObject",300,407,{"name":92,"@type":93},"PakDamar76","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are molecular subtypes important in breast cancer outcomes?","Question",{"text":112,"@type":113},"Patient outcomes and effective therapeutic strategies are frequently determined by molecular subtypes, which reflect biological differences and influence prognosis and treatment response.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do phytochemicals influence epigenetic regulation in preclinical breast cancer models?",{"text":117,"@type":113},"Preclinical studies indicate phytochemicals modulate epigenetic alterations such as DNA methylation, histone modifications, non-coding RNAs, and estrogen-associated epigenetic changes.",{"name":119,"@type":110,"acceptedAnswer":120},"What limits the clinical use of phytochemicals targeting epigenetic markers?",{"text":121,"@type":113},"Despite promising in vitro and in vivo results, clinical application is limited, and further research is needed to confirm effectiveness and safety in clinical settings.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366828,1790217159,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090893057,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Drug Design, Development and Therapy  \n Open Access Full Text Article  \nREVIEW  \nMolecular Insights into Phytochemicals Mediated Epigenetic Regulation in Preclinical Models of Breast Cancer  \nPratibha Pandey 1 , Ali G Alkhathami2 , Mohd Saeed 3 , Khalid Alshaghdali4 , Sandeep Kumar 5 ,  \nTrina Ekawati Tallei 6 , 7 , Hanul Bae8 , Moon Nyeo Park8 , Gaurav Kumar 5 , Bonglee Kim8 , Fahad Khan 9  \n1Centre for Research Impact and Outcome, Chitkara University, Rajpura, Punjab, India; 2Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia; 3Department of Biology, College of Science, University of Hail, Hail, Saudi Arabia; 4Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, University of Hail, Hail, Saudi Arabia; 5Research and Innovation Cell, Bahra University, Waknaghat, HP, India; 6Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Sam Ratulangi, Manado, Indonesia; 7Department of Biology, Faculty of Medicine, Universitas Sam Ratulangi, Manado, Indonesia; 8Department of Pathology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea; 9Center for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, TN-602105, India  \nCorrespondence: Fahad Khan; Bonglee Kim, Email [fahadintegralian@gmail.com](fahadintegralian@gmail.com); [bongleekim@khu.ac.kr](bongleekim@khu.ac.kr)  \n\n| Abstract: One of the most common malignant tumors in women worldwide is breast cancer, which affects even more than one-third of all female tumor patients. Patient outcomes and effective therapeutic strategies are frequently determined by molecular subtypes in breast cancer. However, the underlying epigenetic characteristics that could further divide breast cancer patients into groups and affect their outcomes could be the reason for the differences in therapeutic response. It is true that there have been recent findings about the role of epigenetic abnormalities in cancer, and that therapeutics targeting particular epigenetic pathways have been developed. Phytochemicals function as gene regulators in a variety of cancers and are crucial to the pathophysiology of many human cancers, including breast cancer. Preclinical studies have revealed that phytochemicals exhibit promising therapeutic efficacy against breast carcinoma by modulating several epigenetic alterations including DNA methylation, histone modifications, non-coding RNA and estrogen associated epigenetic changes. Nevertheless, despite promising in vitro and in vivo results, the clinical application of phytochemicals targeting epigenetic markers in breast cancer is limited. Further research is required to confirm their effectiveness and safety in clinical settings. Thus, this study provides a thorough summary of how epigenetic changes contribute to the development of breast cancer. This article also explores the potential benefits of phytochemicals, such as flavonoids, terpenoids, alkaloids, isothiocyanates, and quinones, in modulating these epigenetic markers in preclinical models of breast cancer.\u003Cbr>Keywords: breast cancer, phytochemicals, epigenetic regulation, cancer therapy |\n| --- |\n| Introduction\u003Cbr>Breast cancer continues to be a tough foe of global health challenges. Complex pathophysiology and extensive range of clinical manifestations of breast cancer present significant hurdles for the development of promising treatment and prevention strategies.1,2 Breast cancer can be categorized into three principal subtypes with respect to receptor expression status including luminal A, luminal B, HER2-enriched, and triple-negative variants.3 Various breast cancer subtypes display unique biological characteristics, resulting in differences in prognosis and therapeutic efficacy.4,5\u003Cbr>When classifying breast tumors into various molecular subgroups, the expression levels of HER2, progesterone","cbCaivRNlBwx0Ycu","https://ap.wps.com/l/cbCaivRNlBwx0Ycu","pdf",2981352,18,"English","# Abstract\n# Introduction","[{\"question\":\"Why are molecular subtypes important in breast cancer outcomes?\",\"answer\":\"Patient outcomes and effective therapeutic strategies are frequently determined by molecular subtypes, which reflect biological differences and influence prognosis and treatment response.\"},{\"question\":\"How do phytochemicals influence epigenetic regulation in preclinical breast cancer models?\",\"answer\":\"Preclinical studies indicate phytochemicals modulate epigenetic alterations such as DNA methylation, histone modifications, non-coding RNAs, and estrogen-associated epigenetic changes.\"},{\"question\":\"What limits the clinical use of phytochemicals targeting epigenetic markers?\",\"answer\":\"Despite promising in vitro and in vivo results, clinical application is limited, and further research is needed to confirm effectiveness and safety in clinical settings.\"}]","Molecular Insights into Phytochemicals Mediated Epigenetic Regulation in Preclinical Models of Breast Cancer | PDF",1790167803,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/43fdc1f3593104f690c4c267bf981933.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/78155857725a2fdd026d3d8f3400e21f.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f5f54c5011f1626c586433e2e6fb103e.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a08acfd822fcea6b7b6d9588ab2ebb18.webp",980,1268]